Placebo News and Research

RSS

Novel imaging technique may assist surgeons to improve visualization of ovarian tumors during surgery

A newly devised tumor-specific fluorescent agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery.

15 Jun 2016

Cranberries can reduce symptomatic UTIs and avoid chronic suppressive antibiotics

Today leading experts on infectious disease and urinary tract infections (UTIs) will gather in London to discuss the alarming state of antibiotic resistance, and present findings from a landmark study that conclusively shows that cranberries can be a nutritional approach to reducing symptomatic UTIs, and as a result, may be a useful strategy to decrease worldwide use of antibiotics.

15 Jun 2016

Study characterizes benefits of over-the-counter sleep aid

New research shows that an over-the-counter sleep aid helps people suffering from occasional sleep difficulties fall asleep in less than 20 minutes, on average, and improves their reported quality of sleep.

15 Jun 2016

Liraglutide cardioprotective in high-risk Type 2 diabetes patients

Findings of the LEADER trial show that liraglutide treatment may confer a reduced risk of cardiovascular events in patients with Type 2 diabetes and a high vascular risk.

15 Jun 2016

Mortality risk high among diabetes patients with prior CV events

Patients with Type 2 diabetes and acute coronary syndromes have a substantially increased risk of death in the 18 months after hospital admission for subsequent major nonfatal cardiovascular events, US researchers report.

15 Jun 2016

Caffeine use may not improve alertness after three nights of restricted sleep

A new study found that after restricting sleep to 5 hours per night, caffeine use no longer improved alertness or performance after three nights.

14 Jun 2016

Oxytocin hormone plays role in facilitating perception of emotions

Studies have demonstrated that oxytocin (which acts as an hormone and also as a neurotransmitter in the brain) plays a role in facilitating the perception of emotions in other people's facial expressions.

14 Jun 2016

Clinical trial to test efficacy of new drug for chronic cough

The National Institute for Health Research has today announced its participation in a clinical trial to test a promising new treatment for chronic cough. If approved, this would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough for whom few, if any, effective treatments exist.

14 Jun 2016

Liraglutide drug effectively decreases cardiovascular disease risk in type 2 diabetes patients

Researchers have shown that the glucose-lowering drug liraglutide safely and effectively decreases the overall risk of heart attack, stroke, or cardiovascular death for people with type 2 diabetes.

14 Jun 2016

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk.

14 Jun 2016

Age no barrier to vorapaxar use in ACS

The protease-activated receptor 1 inhibitor vorapaxar offers the same benefits to older and younger patients with non-ST segment elevation acute coronary syndromes, shows further analysis of the TRACER trial.

14 Jun 2016

Blue wavelength light exposure leads to subsequent increases in brain activity in prefrontal cortex

A new study found that blue wavelength light exposure led to subsequent increases in brain activity in the dorsolateral prefrontal cortex (DLPFC) and the ventrolateral prefrontal cortex (VLPFC) when participants were engaging in a cognitive task after cessation of light exposure.

13 Jun 2016

Diabetes-heart disease combination can increase death risk

The combination of type 2 diabetes and coronary artery disease can be deadly. New research from a global study led by a physician from UConn Health has found that patients with Type 2 diabetes admitted into the hospital for congestive heart failure face a one in four chance of dying over the next 18 months.

13 Jun 2016

FDA approves Vaxchora for prevention of cholera

The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the prevention of cholera.

13 Jun 2016

Liraglutide enhances high-dose insulin treatment in Type 2 diabetes

The addition of the glucagon-like peptide 1 receptor agonist liraglutide improves short-term outcomes and treatment satisfaction in patients who have uncontrolled Type 2 diabetes despite high doses of insulin, shows a randomised trial.

12 Jun 2016

New drug ixekizumab helps clear severe psoriasis symptoms

About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term clinical trials led by Northwestern Medicine.

10 Jun 2016

New drug for chronic migraine may reduce headache hours in few days

A new drug to prevent migraine was associated with fewer headache hours for people with chronic migraine within three to seven days after the first injection, according to a study published in the June 8, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Jun 2016

Placebo News and Research

Novel imaging technique may assist surgeons to improve visualization of ovarian tumors during surgery

Cranberries can reduce symptomatic UTIs and avoid chronic suppressive antibiotics

Study characterizes benefits of over-the-counter sleep aid

Liraglutide cardioprotective in high-risk Type 2 diabetes patients

Mortality risk high among diabetes patients with prior CV events

Caffeine use may not improve alertness after three nights of restricted sleep

Oxytocin hormone plays role in facilitating perception of emotions

Clinical trial to test efficacy of new drug for chronic cough

Liraglutide drug effectively decreases cardiovascular disease risk in type 2 diabetes patients

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Age no barrier to vorapaxar use in ACS

Blue wavelength light exposure leads to subsequent increases in brain activity in prefrontal cortex

Diabetes-heart disease combination can increase death risk

FDA approves Vaxchora for prevention of cholera

Liraglutide enhances high-dose insulin treatment in Type 2 diabetes

New drug ixekizumab helps clear severe psoriasis symptoms

New drug for chronic migraine may reduce headache hours in few days

Most antidepressants are ineffective at treating children and teens, study shows

Migraine drug has quick onset of action

Study finds no added benefit of empagliflozin alone or in combination for type 2 diabetes

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News